The majority of molecular diagnostics systems available on the market today are extremely complex and require considerable hands-on time in addition to highly qualified laboratory personnel. As such, their availability for use is very limited to central laboratories and specialist laboratories.
With the Unyvero solution, Curetis has introduced a brand-new molecular diagnostics system to the market. This new system enables reliable and extremely rapid diagnosis of severe infectious diseases within just four to five hours. The system tests a wide variety of pathogens and antibiotic resistance markers simultaneously.
Curetis Publishes Business and Financial Update for the First Nine Months of 2017
Curetis initiates U.S. FDA study for Unyvero Invasive Joint Infections Cartridge
37ème Réunion Interdisciplinaire de Chimiothérapie Anti-Infectieuse - Paris, France - December 18 to 19, 2017
Reanimation Congress 2018 - Paris, France - 24 to 26 January, 2018